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Background:
Kernicterus Spectrum Disorders (KSDs) result from hyperbilirubinemia-induced brain injury. While rare,
KSDs can result in devastating neurologic sequelae affecting motor function and tone, causing dystonia and
choreoathetosis, and/or auditory neuropathy spectrum disorders. Families of children with undiagnosed
neurodevelopmental disorders and a history of neonatal hyperbilirubinemia often question this potential
diagnosis. We developed a Toolkit (KSD-TK) questionnaire in an effort to provide a standardized method to
predict the likelihood of KSDs.

Objectives/Goal:
This study compares the accuracy of the KSD-TK to clinical diagnoses made by our Children’s Mercy
Hospital Kernicterus Center of Excellence (KCOE). The primary objective of this study is to determine how
accurate the KSD-TK is in predicting a KSD diagnosis. The secondary objective is to determine which risk
factors included on the KSD-TK are most predictive of a KSD diagnosis.

Methods/Design:
We retrospectively reviewed charts of 37 patients evaluated between 2011-2019 at the KCOE. We
completed a KSD-TK for each patient using data including highest bilirubin, newborn risk factors, neonatal

exam, follow-up exam, auditory testing, presence or absence of enamel dysplasia, and MRI brain results.
KSD-TK diagnostic prediction was compared to “gold standard” clinical diagnoses given after KCOE
evaluation and used to calculate sensitivity and specificity of the KSD-TK as well as sensitivity, specificity,
area under the curve, and accuracy of each risk factor included on the KSD-TK.

Results:
Of the 37 patients, 29 were clinically diagnosed with and 8 without kernicterus. All 14 patients with KSD-TK
“definite” kernicterus and 14 of 15 patients with KSD-TK “probable” kernicterus were clinically diagnosed
with kernicterus. One of 2 patients with KSD-TK “possible” kernicterus was diagnosed with kernicterus.
None of 6 patients with KSD-TK “not kernicterus” were clinically diagnosed with kernicterus. When KSD-TK
“definite” and “probable” are combined, the sensitivity of the KSD-TK is 96.6%, while the specificity is
87.5%. Each component of the KSD-TK had a high sensitivity, but only three had a specificity >0.25:
auditory testing, follow-up exam, and MRI results.

Conclusions:
The KSD-TK is a promising tool for diagnosing kernicterus with a sensitivity of 96.6% and specificity of
87.5%. Utilizing the KSD-TK as a standardized screening tool could lead to more prompt diagnoses, fewer
missed diagnoses, and earlier treatment especially in resource limited settings. Future studies will attempt
to replicate these results using KSD-TK’s completed by families and referring providers.

